Catalyst
Slingshot members are tracking this event:
KMDA's Phase 2 data for Alpha-1 Antitrypsin for Pediatric Patients newly diagnosed with Type 1 diabetes Expected Q3 2017
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| KMDA |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jan 08, 2018
Occurred Source:
http://www.kamada.com/news_item.php?ID=313
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 2/3 Study, Type 1 Diabetes
